Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (12800)	12/22/1997 10:26:00 PM
From: tonyt	Read Replies (2) \| Respond to of 32384

> I think the biotech weakness is due to Asia concerns I can understand why techs (i.e. DELL, CPQ), who have a decent percentage of revenues from Asia falling on these concerns, but most biotechs do not have this problem. > and the unwillingness to put money into stocks that are not making it. More likely the cause of the decline rather than Asia concerns.

To: Andrew H who wrote (12800)	12/23/1997 1:14:00 PM
From: Machaon	Read Replies (3) \| Respond to of 32384

<< I think tax loss selling has been finished for a while. >> Most of the trading, that has chased biotechs down towards their 52 week lows, has been small trades. To me, it looks like the big money is staying away, for now, and letting the tax selling have it's way. Are the funds, MM's and insurance companies, etc., just nibbling away, or waiting in the wings? Who knows!? Buts....... I agree with you. It appears that the tax loss selling is slowing, or, new "retail" money coming into the market is compensating for the tax loss selling. Biotechs usually are, IMHO, positively effected by low interest rates. Right now, financing is as cheap as it gets. With biotechs at these bargain, basement prices, perhaps we get the "Mother of all Biotech rallies" next year. At least we can hope, right? Regards and best of the holidays, Bob